These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33256274)

  • 1. [Liver cancer immunotherapy in the context of precision medicine].
    Huan HB; Chen XJ; Xia F
    Zhonghua Gan Zang Bing Za Zhi; 2020 Nov; 28(11):910-914. PubMed ID: 33256274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Research progress of immunotherapy alone and in combination for liver cancer].
    Wu ZJL; Li K; Zhang K; Gong WD
    Zhonghua Gan Zang Bing Za Zhi; 2020 Jun; 28(6):471-474. PubMed ID: 32660173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment strategy for hepatocellular carcinoma in China: radiofrequency ablation versus liver resection.
    Zhu ZX; Huang JW; Liao MH; Zeng Y
    Jpn J Clin Oncol; 2016 Dec; 46(12):1075-1080. PubMed ID: 27677661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Progress in immunotherapy for hepatocellular carcinoma].
    Shen Z; Li M; Bai S; Yang Q; Zhang F; Tang M; Guo J; Yang Z
    Sheng Wu Gong Cheng Xue Bao; 2019 Dec; 35(12):2326-2338. PubMed ID: 31880139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutics for advanced hepatocellular carcinoma: Recent advances, current dilemma, and future directions.
    Zhu J; Yin T; Xu Y; Lu XJ
    J Cell Physiol; 2019 Aug; 234(8):12122-12132. PubMed ID: 30644100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in radiotherapy and immunity in hepatocellular carcinoma.
    Yang Y; Xiong L; Li M; Jiang P; Wang J; Li C
    J Transl Med; 2023 Aug; 21(1):526. PubMed ID: 37542324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy for hepatocellular carcinoma.
    Li S; Yang F; Ren X
    Drug Discov Ther; 2015 Oct; 9(5):363-71. PubMed ID: 26632545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical advances in targeted therapy and immunotherapy for hepatocellular carcinoma].
    Zhang DZ; Niu JQ
    Zhonghua Gan Zang Bing Za Zhi; 2019 Nov; 27(11):834-837. PubMed ID: 31941237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precision Medicine: Update on Diagnosis and Therapeutic Strategies of Hepatocellular Carcinoma.
    Liang Q; Shen X; Sun G
    Curr Med Chem; 2018; 25(17):1999-2008. PubMed ID: 29345573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advances in basic and clinical research on hepatocellular carcinoma in 2016].
    Dong ZZ; Zhu XD; Li Z; Mao YG; Chai YL; Yao DF; Sun HC; Zhu JY; Ma KS
    Zhonghua Gan Zang Bing Za Zhi; 2017 Feb; 25(2):85-93. PubMed ID: 28297792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The advanced development of molecular targeted therapy for hepatocellular carcinoma.
    Yan T; Yu L; Zhang N; Peng C; Su G; Jing Y; Zhang L; Wu T; Cheng J; Guo Q; Shi X; Lu Y
    Cancer Biol Med; 2022 Jun; 19(6):802-17. PubMed ID: 35699406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Strategies and challenges of immunotherapy for hepatocellular carcinoma].
    Zhang HH; Chen HS
    Zhonghua Gan Zang Bing Za Zhi; 2020 Jun; 28(6):457-460. PubMed ID: 32660170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
    Marotta F; Vangieri B; Cecere A; Gattoni A
    Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in surgical and nonsurgical approaches for hepatocellular carcinoma treatment.
    Yegin EG; Oymaci E; Karatay E; Coker A
    Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):234-56. PubMed ID: 27298100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress of targeted and immunotherapy for hepatocellular carcinoma and the application of next-generation sequencing.
    Yang F; Deng K; Zheng H; Liu Z; Zheng Y
    Ann Hepatol; 2022; 27(2):100677. PubMed ID: 35093601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current treatment in advanced hepatocellular carcinoma and prospects for immuno-oncology therapy].
    Xu JM
    Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):561-565. PubMed ID: 28835076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current management of hepatocellular carcinoma.
    Zhou XD; Tang ZY; Yu YQ; Hou Z
    Hepatogastroenterology; 1991 Dec; 38 Suppl 1():46-55. PubMed ID: 1668377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial Intelligence and Precision Medicine: Outcome of Immunotherapy in Hepatocellular Carcinoma.
    Theodros E; Nagaraju GP
    Crit Rev Immunol; 2022; 42(6):1-8. PubMed ID: 37082946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy of hepatocellular carcinoma.
    Butterfield LH; Ribas A
    Expert Opin Biol Ther; 2002 Feb; 2(2):123-33. PubMed ID: 11849113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Hepatocellular carcinoma: A life-threatening disease".
    Chacko S; Samanta S
    Biomed Pharmacother; 2016 Dec; 84():1679-1688. PubMed ID: 27823920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.